SETIAWAN, S.I. and ASCOBAT, P. 2019. ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA. International Journal of Applied Pharmaceutics. 11, 6 (Dec. 2019), 80–83. DOI:https://doi.org/10.22159/ijap.2019.v11s6.33551.